---
title: Viralgen vs VVector Bio
slug_a: viralgen
slug_b: vvectorbio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/viralgen/vvectorbio
generated_by: BioBM Editorial AI
---

# Viralgen vs VVector Bio

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Viralgen (viralgen) is listed for cdmo. Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.

Services: 4. Modalities: 2. Indications: 1. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

VVector Bio (vvectorbio) is listed for cdmo. VVector Bio is a spin-out of McGill University developing cutting-edge technologies for cost-effective manufacturing of cell and gene therapies.

Services: 1. Modalities: 3. Indications: 2. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in modalities (3).

Review summary: Review summary withheld until site-level review gate opens.